Clinicopathological Significance of VEGF-C, VEGFR-3 and Cyclooxygenase-2 in Early-Stage Cervical Cancer.

about

Lactate transporters and vascular factors in HPV-induced squamous cell carcinoma of the uterine cervix.Reprogramming energy metabolism and inducing angiogenesis: co-expression of monocarboxylate transporters with VEGF family members in cervical adenocarcinomas.

P2860

Q34346085-478E7C7D-3796-4BCA-9264-BE1B9AE8BC39 Q35829579-DF7A5567-08F8-4247-871E-5215635626F6

P2860

Clinicopathological Significance of VEGF-C, VEGFR-3 and Cyclooxygenase-2 in Early-Stage Cervical Cancer.

Item

http://www.wikidata.org/entity/Q36735345

description

2008 nî lūn-bûn

@nan

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

2008年论文

@zh

2008年论文

@zh-cn

name

Clinicopathological Significan ...... n Early-Stage Cervical Cancer.

@ast

Clinicopathological Significan ...... n Early-Stage Cervical Cancer.

@en

type

Item

label

Clinicopathological Significan ...... n Early-Stage Cervical Cancer.

@ast

Clinicopathological Significan ...... n Early-Stage Cervical Cancer.

@en

prefLabel

Clinicopathological Significan ...... n Early-Stage Cervical Cancer.

@ast

Clinicopathological Significan ...... n Early-Stage Cervical Cancer.

@en

P1476

Clinicopathological Significan ...... n Early-Stage Cervical Cancer.

@en

P2093

Beibei Wang

http://www.w3.org/2001/XMLSchema#string

Danhui Weng

http://www.w3.org/2001/XMLSchema#string

Ding Ma

http://www.w3.org/2001/XMLSchema#string

Gang Chen

http://www.w3.org/2001/XMLSchema#string

Jianfeng Zhou

http://www.w3.org/2001/XMLSchema#string

Juncheng Wei

http://www.w3.org/2001/XMLSchema#string

Ling Xi

http://www.w3.org/2001/XMLSchema#string

Peng Wu

http://www.w3.org/2001/XMLSchema#string

Xiaohong Song

http://www.w3.org/2001/XMLSchema#string

Xiaoyan Shi

http://www.w3.org/2001/XMLSchema#string

P2860

A novel vascular endothelial growth factor, VEGF-C, is a ligand for the Flt4 (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinases

Vascular endothelial growth factor (VEGF)-C signaling through FLT-4 (VEGFR-3) mediates leukemic cell proliferation, survival, and resistance to chemotherapy

Proinflammatory cytokines regulate expression of the lymphatic endothelial mitogen vascular endothelial growth factor-C

Chemoprevention of intestinal polyposis in the Apcdelta716 mouse by rofecoxib, a specific cyclooxygenase-2 inhibitor

Cyclooxygenases: structural, cellular, and molecular biology

FLT4 receptor tyrosine kinase contains seven immunoglobulin-like loops and is expressed in multiple human tissues and cell lines.

Blockade of vascular endothelial growth factor receptor-3 signaling inhibits fibroblast growth factor-2-induced lymphangiogenesis in mouse cornea.

Cyclooxygenase-2 induces EP1- and HER-2/Neu-dependent vascular endothelial growth factor-C up-regulation: a novel mechanism of lymphangiogenesis in lung adenocarcinoma.

Expression of the fms-like tyrosine kinase 4 gene becomes restricted to lymphatic endothelium during development.

Vascular endothelial growth factors VEGF-B and VEGF-C are expressed in human tumors.

P304

58-63

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Shixuan Wang

P577

2008-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23675067

http://www.w3.org/2001/XMLSchema#string

P932

3614667

http://www.w3.org/2001/XMLSchema#string

Clinicopathological Significance of VEGF-C, VEGFR-3 and Cyclooxygenase-2 in Early-Stage Cervical Cancer.

about

P2860

P2860

Clinicopathological Significance of VEGF-C, VEGFR-3 and Cyclooxygenase-2 in Early-Stage Cervical Cancer.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P433

P478

P50

P577

P698

P932

P1433

P1476

P2093

P2860

P304

P31

P433

P478

P50

P577

P698

P932